Dot Compliance

FEBRUARY 1, 2022

The race to develop a COVID-19 vaccine highlighted the power of artificial intelligence (AI) and machine learning (ML) as Johnson & Johnson, Moderna and Pfizer employed these technologies to swiftly get their vaccines to market. The next evolution is for companies to implement Industry 4.0 References. References.

FDA 52

FDA COVID-19 Vaccine Pharmaceutical Industry COVID-19 52

SQA

JUNE 10, 2021

183/2017, which provides the procedures to obtain the Brazilian Good Manufacturing Practices (BGMP) Certification for medical devices. Backgrounder – Government of Canada Investments in Biomanufacturing, Development of COVID-19 Vaccines and Therapeutics, and Research, 18 May 2021. Regularization of orthopedic implants.

FDA 52

FDA COVID-19 COVID-19 Vaccine Compliance 52

Hall Render

JANUARY 28, 2022

COVID-positive employees returning to work: 2 CEOs share their protocols. FDA halts use of antibody drugs that don’t work vs. omicron. Where Hospital Price Transparency Compliance Is Lagging. With a vaccine mandate looming, nursing homes face more staffing problems. Oklahoma health agency modifying COVID-19 testing hours.

Nursing Homes 40

Nursing Homes COVID-19 US Department of Health and Human Services Nurses 40

Drug & Device Law

DECEMBER 29, 2023

Since the FDA requires pre-approval of any warnings about off-label uses, preemption at some point should have been pre-ordained under the Mensing ( 2011+1 ) independence principle, but off-label use did not really figure in Zofran ’s analysis. The FDA’s five reviews of teratogenic risk all came to the same conclusion.

FDA 105

FDA US Department of Health and Human Services COVID-19 Informed Consent 105